We are live on ! Find out more
FULC icon

Fulcrum Therapeutics

47 hedge funds and large institutions have $201M invested in Fulcrum Therapeutics in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

380% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 5

300% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 3

24% more funds holding

Funds holding: 3847 (+9)

4.42% more ownership

Funds ownership: 67.63%72.05% (+4.4%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

23% less capital invested

Capital invested by funds: $262M → $201M (-$61.1M)

Holders
47
Holders Change
+9
Holders Change %
+23.68%
% of All Funds
1.04%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
12
Increased
24
Reduced
5
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
State of Wisconsin Investment Board
26
State of Wisconsin Investment Board
Wisconsin
$233K +$312K +19,500 New
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$229K +$197K +12,312 +179%
FAM
28
Fred Alger Management
New York
$194K -$504K -31,500 -66%
Bank of America
29
Bank of America
North Carolina
$186K +$219K +13,665 +739%
BM
30
Brandywine Managers
Delaware
$184K +$64K +4,000 +35%
Squarepoint
31
Squarepoint
New York
$166K +$222K +13,878 New
Jacobs Levy Equity Management
32
Jacobs Levy Equity Management
New Jersey
$134K +$179K +11,192 New
Los Angeles Capital Management
33
Los Angeles Capital Management
California
$127K +$170K +10,629 New
Wells Fargo
34
Wells Fargo
California
$109K +$114K +7,129 +358%
Victory Capital Management
35
Victory Capital Management
Texas
$102K +$72.3K +4,521 +114%
UBS Group
36
UBS Group
Switzerland
$97K +$32.1K +2,006 +33%
AIG
37
American International Group
New York
$89K +$74.2K +4,638 +163%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$69K
Deutsche Bank
39
Deutsche Bank
Germany
$56K +$50K +3,126 +207%
Citigroup
40
Citigroup
New York
$44K +$44.3K +2,767 +303%
SO
41
STRS Ohio
Ohio
$38K +$32K +2,000 +167%
MAM
42
Meeder Asset Management
Ohio
$28K +$37.4K +2,336 New
Legal & General Group
43
Legal & General Group
United Kingdom
$25K +$14.6K +911 +89%
AIP
44
Ameritas Investment Partners
Nebraska
$13K +$11.5K +720 +189%
MLICM
45
Metropolitan Life Insurance Company (MetLife)
New York
$12.1K +$16.2K +1,015 New
AIS
46
Accurate Investment Solutions
Pennsylvania
$4K +$4.8K +300 New
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$1K -$6.32K -395 -88%
Alyeska Investment Group
48
Alyeska Investment Group
Illinois
-$1.26M -75,551 Closed
LCM
49
Laurion Capital Management
New York
-$558K -33,552 Closed
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
-$10K -571 Closed

FULC Hedge Fund Activity: Q1 2020 in Review

47 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q1 2020, worth a combined $201M — down 23% from $262M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new FULC positions and 3 closed out — a net gain of 9 holders — while 24 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, adding an estimated $6.57M. The largest seller was Foresite Capital Management IV, cutting an estimated $8.02M.

  • 47 institutional investors held Fulcrum Therapeutics (FULC) as of Q1 2020, up from 38 in Q4 2019.
  • Funds reported $201M of Fulcrum Therapeutics stock for Q1 2020, down 23% quarter-over-quarter.
  • 12 funds opened new Fulcrum Therapeutics positions in Q1 2020 and 3 closed out, a net change of +9 holders.
  • The largest Fulcrum Therapeutics buyer in Q1 2020 was BlackRock, an estimated $6.57M added.
  • The largest Fulcrum Therapeutics seller in Q1 2020 was Foresite Capital Management IV, an estimated $8.02M sold.

Based on aggregated 13F filings for Q1 2020.